0001819934-21-000003.txt : 20211222 0001819934-21-000003.hdr.sgml : 20211222 20211222111658 ACCESSION NUMBER: 0001819934-21-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211222 DATE AS OF CHANGE: 20211222 EFFECTIVENESS DATE: 20211222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AmbAgon Therapeutics Inc. CENTRAL INDEX KEY: 0001819934 IRS NUMBER: 850560627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-372342 FILM NUMBER: 211511685 BUSINESS ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: (415) 235-6373 MAIL ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 D/A 1 primary_doc.xml X0708 D/A LIVE 0001819934 AmbAgon Therapeutics Inc. 953 INDIANA STREET SAN FRANCISCO CA CALIFORNIA 94107 (415) 235-6373 DELAWARE None None Corporation true 2020 Christian Ottmann c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Michelle Arkin c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Janwillem Naesens c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Margarita Chavez c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Peter Dudek c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Roel Bulthuis c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Adam Rosenberg c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Scott Clarke c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Director Josh Seidenfeld c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Nancy Pryer c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Bryan Miller c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Biotechnology Decline to Disclose 06b true 0001819934-21-000001 2021-12-07 true true false 0 5399998 5399998 0 Series Seed Preferred Stock and the Common Stock issuable upon the conversion thereof. false 8 0 0 0 false AmbAgon Therapeutics Inc. /s/Scott Clarke Scott Clarke Chief Executive Officer 2021-12-22